amlodipine 5 MG Oral Tablet [Norvasc]
- RxCUI
- 212549
- RxNorm name
- amlodipine 5 MG Oral Tablet [Norvasc]
- Display name
- NORVASC (Oral Pill)
- Full name
- amlodipine 5 MG Oral Tablet [Norvasc]
- Term type
- SBD
- Status
- Active
- Strength
- 5 mg
- Dose form
- Tab
- Route
- Oral Pill
- Updated
- 2026-11-14 08:24:05
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 042005
- Active start
- 042005
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| amlodipine besylate | 5 MG / 1 EACH | amlodipine | amlodipine |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Tablet | 317541 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| amlodipine | 17767 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | Norvasc 5 MG Oral Tablet | 1 | NAMES |
| RxNorm Name | amlodipine 5 MG Oral Tablet [Norvasc] | 1 | NAMES |
| RxNorm Synonym | 2 | NAMES | |
| TTY | SBD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 212549 | 1 | CODES |
| MMSL_CODE | BD606 | 1 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0069-1530-68 | 0069-1530 | Norvasc amlodipine besylate | PFIZER LABORATORIES DIV PFIZER INC | NDA019787 |
| 58151-354-30 | 58151-354 | Norvasc amlodipine besylate | Viatris Specialty LLC | NDA019787 |
| 58151-354-77 | 58151-354 | Norvasc amlodipine besylate | Viatris Specialty LLC | NDA019787 |
| 58151-354-88 | 58151-354 | Norvasc amlodipine besylate | Viatris Specialty LLC | NDA019787 |
Drugs@FDA Applications#
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Norvasc | AMLODIPINE BESYLATE | Viatris Specialty LLC | 7367289c-b0b0-466a-83e2-558e2985c29f | 2023-02-15 | Warnings, Adverse reactions | 58151-354-30 58151-354-77 58151-354-88 58151-354 58151035430 58151035488 58151035477 212549 |
| Norvasc | AMLODIPINE BESYLATE | PFIZER LABORATORIES DIV PFIZER INC | abd6a2ca-40c2-485c-bc53-db1c652505ed | 2019-01-15 | Warnings, Adverse reactions | 0069-1530-68 0069-1530 00069153072 00069153041 00069153068 212549 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| abd6a2ca-40c2-485c-bc53-db1c652505ed | Norvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY] | 4 | 29 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | 20190115 |
| 7367289c-b0b0-466a-83e2-558e2985c29f | Norvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY] | 4 | 10 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | 20230215 |
| b00570ff-4081-4514-b45b-eb6f753450f5 | Norvasc 5 MG Oral Tablet [PSN] · amlodipine 5 MG Oral Tablet [Norvasc] [SBD] · Norvasc (as amlodipine besylate) 5 MG Oral Tablet [SY] · Norvasc 5 MG Oral Tablet [SY] | 4 | 1 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1987 | 20101228 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 7367289c-b0b0-466a-83e2-558e2985c29f | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | Viatris Specialty LLC | 20230215 |
| fc285a1f-9b43-4bdf-8679-44e25654b84c | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PD-Rx Pharmaceuticals, Inc. | 20220418 |
| abd6a2ca-40c2-485c-bc53-db1c652505ed | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1992 | PFIZER LABORATORIES DIV PFIZER INC | 20190115 |
| 182453c3-87dd-47a4-aa53-7c54995d74fb | National Council for Prescription Drug Programs | 20120724 | |
| 3bafdaac-fccd-4fdb-904e-5c1b7a5d3fce | National Council for Prescription Drug Programs | 20120724 | |
| 4063d41e-0822-47a5-960c-43bdf7dfe5a4 | National Council for Prescription Drug Programs | 20120724 | |
| 8801fad1-126b-49e9-9b30-ed21a3ece578 | National Council for Prescription Drug Programs | 20120724 | |
| 92cdc86c-83f1-4e61-944f-70612e605f56 | National Council for Prescription Drug Programs | 20120724 | |
| a16bbc6c-972f-430d-bac6-bd31174117ea | National Council for Prescription Drug Programs | 20120724 | |
| dd95de65-d368-40c3-aa09-7f4dee8f9dcc | National Council for Prescription Drug Programs | 20120724 | |
| b00570ff-4081-4514-b45b-eb6f753450f5 | These highlights do not include all the information needed to use NORVASC safely and effectively. See full prescribing information for NORVASC. NORVASC ® (amlodipine besylate) Tablets for oral administration Initial U.S. Approval: 1987 | Rebel Distributors Corp | 20101228 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | C08CA | Dihydropyridine derivatives | ATC1-4 | amlodipine | |
| FDASPL | D004095 | Dihydropyridines | CHEM | has_chemical_structure | amlodipine |
| FDASPL | N0000175566 | Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000175421 | Dihydropyridine Calcium Channel Blocker | EPC | has_epc | amlodipine |
| FDASPL | N0000000069 | Calcium Channel Antagonists | MOA | has_moa | amlodipine |
| FDASPL | N0000190114 | Cytochrome P450 3A Inhibitors | MOA | has_moa | amlodipine |
| MEDRT | D017311 | Amlodipine | CHEM | has_ingredient | amlodipine |
| MEDRT | D000788 | Angina Pectoris, Variant | DISEASE | may_treat | amlodipine |
| MEDRT | D003324 | Coronary Artery Disease | DISEASE | may_treat | amlodipine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | amlodipine |
| MEDRT | D006973 | Hypertension | DISEASE | may_treat | amlodipine |
| MEDRT | D007022 | Hypotension | DISEASE | ci_with | amlodipine |
| MEDRT | N0000020065 | L-Calcium Channel Receptor Antagonists | MOA | has_moa | amlodipine |
| MEDRT | N0000008375 | Coronary Arterial Vasodilation | PE | has_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | ci_pe | amlodipine |
| MEDRT | N0000178477 | Decreased Blood Pressure | PE | has_pe | amlodipine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 5 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| CODES | NDA | NDA019787 |
| NAMES | Prescribable Synonym | Norvasc 5 MG Oral Tablet |
| NAMES | Tallman Synonym | amLODIPine 5 MG Oral Tablet [Norvasc] |
| NAMES | Tallman Synonym | Norvasc (as amLODIPine besylate) 5 MG Oral Tablet |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |